Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.

Health Policy

Institute of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Electronic address:

Published: May 2015

Competitive health insurance markets will only enhance cost-containment, efficiency, quality, and consumer responsiveness if all consumers feel free to easily switch insurer. Consumers will switch insurer if their perceived switching benefits outweigh their perceived switching costs. We developed a conceptual framework with potential switching benefits and costs in competitive health insurance markets. Moreover, we used a questionnaire among Dutch consumers (1091 respondents) to empirically examine the relevance of the different switching benefits and costs in consumers' decision to (not) switch insurer. Price, insurers' service quality, insurers' contracted provider network, the benefits of supplementary insurance, and welcome gifts are potential switching benefits. Transaction costs, learning costs, 'benefit loss' costs, uncertainty costs, the costs of (not) switching provider, and sunk costs are potential switching costs. In 2013 most Dutch consumers switched insurer because of (1) price and (2) benefits of supplementary insurance. Nearly half of the non-switchers - and particularly unhealthy consumers - mentioned one of the switching costs as their main reason for not switching. Because unhealthy consumers feel not free to easily switch insurer, insurers have reduced incentives to invest in high-quality care for them. Therefore, policymakers should develop strategies to increase consumer choice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2014.11.015DOI Listing

Publication Analysis

Top Keywords

switching benefits
20
switch insurer
16
costs
12
benefits costs
12
competitive health
12
health insurance
12
insurance markets
12
switching costs
12
potential switching
12
switching
10

Similar Publications

Introduction: The standard of care for stage III colon cancer is 3 or 6 months of double-drug regimen chemotherapy following radical surgery. However, patients with positive circulating tumour DNA (ctDNA) exhibit a high risk of recurrence risk even if they receive standard adjuvant chemotherapy. The potential benefit of intensified adjuvant chemotherapy, oxaliplatin, irinotecan, leucovorin and fluoropyrimidine (FOLFOXIRI), for ctDNA-positive patients remains to be elucidated.

View Article and Find Full Text PDF

Purpose Of Review: To summarize current evidence regarding the indication of adjuvant treatment after transoral laser microsurgery (TOLMS).

Recent Findings: Apart from well known risk factors, margins represent the key point in the decision-making. If margins are affected, additional treatment is mandatory.

View Article and Find Full Text PDF

High-performance triboelectric nanogenerator employing a swing-induced counter-rotating motion mechanism and a dual potential energy storage and release strategy for wave energy harvesting.

Mater Horiz

January 2025

School of Materials Science and Engineering, Energy Materials and Devices Key Lab of Anhui Province for Photoelectric Conversion, Anhui University, Hefei, Anhui 230601, China.

The triboelectric nanogenerator (TENG) has been proved to be a very promising marine energy harvesting technology. Herein, we have developed a high-performance triboelectric nanogenerator (SD-TENG) with low friction, high durability, swing-induced counter-rotating motion mechanism (SICRMM) and dual potential energy storage and release strategy (DPESRS). The unique counter-rotating motion mechanism enabled SD-TENG to convert the external linear and swing motion energy into rotation motion energy of the inner and outer cylinders, and then converted it into a controllable power output.

View Article and Find Full Text PDF

Introduction: Antiretroviral treatment (ART) has significantly enhanced health outcomes for people living with HIV (PLWH). With the evolution of treatment options, there is an increasing interest in the development of long-acting injectable formulations of antiretroviral drugs. These formulations present a promising alternative to oral ART.

View Article and Find Full Text PDF

Learning to hear again with alternating cochlear frequency allocations.

Sci Rep

January 2025

Department of ENT/Audiology & School for Mental Health and NeuroScience (MHENS), Maastricht University Medical Centre, Maastricht, The Netherlands.

Traditionally, the place-pitch 'tonotopically' organized auditory neural pathway was considered to be hard-wired. Cochlear implants restore hearing by arbitrarily mapping frequency-amplitude information. This study shows that recipients, after a long period of sound deprivation, preserve a level of auditory plasticity, enabling them to swiftly and concurrently learn speech understanding with two alternating, distinct frequency maps.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!